Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176845 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181628 |
| TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184171 |
| TEVA-TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2023-02-16 | 2023-04-28 | 184940 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2023-02-16 | 2023-04-28 | 184943 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-09 | 2023-04-28 | 119904 |
| TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2021-03-11 | 2023-04-28 | 135552 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161976 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2022-06-09 | 2023-04-28 | 162309 |
| TEVA-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167200 |
| TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2022-03-10 | 2023-05-23 | 156415 |
| TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167168 |
| TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167174 |
| TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167177 |
| TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167179 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2021-02-05 | 2023-06-09 | 133460 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2023-02-09 | 2023-06-09 | 184225 |
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2023-04-27 | 2023-06-09 | 190731 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144694 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |